One of the main findings of our study is that a persistent CRP−positivity (of >5 mg/L for at least 1.5 consecutive years), and thus, chronic low-grade inflammation in SSc patients is associated with a significantly higher estimated 10-year risk for ASCVD risk than SSc patients without CRP elevations. This evidence concerns the gene CRP and systemic sclerosis.